Abstract:Ferroptosis is a newly described form of regulated cell death, distinct from apoptosis, necroptosis and other forms of cell death. Ferroptosis is induced by disruption of glutathione synthesis or inhibition of glutathione peroxidase 4, exacerbated by iron, and prevented by radical scavengers such as ferrostatin-1, liproxstatin-1, and endogenous vitamin E. Ferroptosis terminates with mitochondrial dysfunction and toxic lipid peroxidation. Although conclusive identification of ferroptosis in vivo is challenging, several salient and very well established features of neurodegenerative diseases are consistent with ferroptosis, including lipid peroxidation, mitochondrial disruption and iron dysregulation. Accordingly, interest in the role of ferroptosis in neurodegeneration is escalating and specific evidence is rapidly emerging. One aspect that has thus far received little attention is the antioxidant transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2). This transcription factor regulates hundreds of genes, of which many are either directly or indirectly involved in modulating ferroptosis, including metabolism of glutathione, iron and lipids, and mitochondrial function. This potentially positions Nrf2 as a key deterministic component modulating the onset and outcomes of ferroptotic stress. The minimal direct evidence currently available is consistent with this and indicates that Nrf2 may be critical for protection against ferroptosis. In contrast, abundant evidence demonstrates that enhancing Nrf2 signaling is potently neuroprotective in models of neurodegeneration, although the exact mechanism by which this is achieved is unclear. Further studies are required to determine to extent to which the neuroprotective effects of Nrf2 activation involve the prevention of ferroptosis.

Targeting Nrf2 to Suppress Ferroptosis and Mitochondrial Dysfunction in Neurodegeneration

Nrf2 and Ferroptosis: A New Research Direction for Neurodegenerative Diseases

NRF2, a Superstar of Ferroptosis

Fostered Nrf2 expression antagonizes iron overload and glutathione depletion to promote resistance of neuron-like cells to ferroptosis

Nrf2 and Ferroptosis: Exploring Translational Avenues for Therapeutic Approaches to Neurological Diseases

Targeting Ferroptosis for Cancer Therapy: Exploring Novel Strategies from Its Mechanisms and Role in Cancers

Toward Improved Human Health: Nrf2 Plays a Critical Role in Regulating Ferroptosis

Targeting NRF2 to Suppress Ferroptosis in Brain Injury.

Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

The role of non-coding RNAs in ferroptosis regulation

The regulation and function of Nrf2 signaling in ferroptosis-activated cancer therapy

Mitochondrial oxidative stress mediated Fe-induced ferroptosis via the NRF2-ARE pathway

NFE2L1-mediated proteasome function protects from ferroptosis

New insights into crosstalk between Nrf2 pathway and ferroptosis in lung disease

Nrf2-Mediated Ferroptosis Inhibition Exerts a Protective Effect on Acute-on-Chronic Liver Failure

NRF2 controls iron homeostasis and ferroptosis through HERC2 and VAMP8

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Targeting Nuclear Factor Erythroid 2-Related Factor 2-Regulated Ferroptosis to Treat Nervous System Diseases

Ferroptosis and its potential as a therapeutic target

Epigenetic Regulation of Ferroptosis in Central Nervous System Diseases

Nutritional and Metabolic Control of Ferroptosis